Water quality report for Palatka, FL — PFAS, lead and copper results, violation history and state inspection findings from EPA SDWIS.
A look at Palatka's drinking water using EPA enforcement records: violations, lead and copper results, PFAS sampling and state inspection findings.
Lead is 16.80 ppb, 112% of the action level and no violations are open. No PFAS was detected.
Graded on violations, lead, and PFAS, with state inspection findings.
| Contaminant | Type | Measured | Limit | Period | Status |
|---|---|---|---|---|---|
| E. COLI | MONITORING AND REPORTING | — | 0 | 2026 | Archived |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2026 | Archived |
| Revised Total Coliform Rule | REPORTING FAILURE | — | — | 2025 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2025 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2025 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2025 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2025 | Resolved |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2024 | Archived |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2024 | Archived |
| TTHM | MCL EXCEEDANCE | 123.05 UG/L | 0.080 mg/L | 2024 | Archived |
| Consumer Confidence Rule | OTHER | — | — | 2024 | Unaddressed |
| TTHM | MCL EXCEEDANCE | 97.9 UG/L | 0.080 mg/L | 2024 | Archived |
| TTHM | MCL EXCEEDANCE | 106.75 UG/L | 0.080 mg/L | 2024 | Archived |
| TTHM | MCL EXCEEDANCE | 155.75 UG/L | 0.080 mg/L | 2024 | Archived |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2024 | Archived |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2024 | Archived |
| Nitrate | MONITORING AND REPORTING | — | 10 mg/L | 2024 | Archived |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2023 | Resolved |
| TTHM | MCL EXCEEDANCE | 155.75 UG/L | 0.080 mg/L | 2023 | Archived |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2023 | Archived |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2023 | Archived |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2023 | Archived |
| TTHM | MCL EXCEEDANCE | 152.9333 UG/L | 0.080 mg/L | 2023 | Archived |
| TTHM | MCL EXCEEDANCE | 145.8333 UG/L | 0.080 mg/L | 2023 | Archived |
| TTHM | MONITORING AND REPORTING | — | 0.080 mg/L | 2023 | Archived |
| TTHM | MCL EXCEEDANCE | 132.175 UG/L | 0.080 mg/L | 2023 | Archived |
| Lead and Copper Rule | MONITORING AND REPORTING | — | TT | 2023 | Unaddressed |
| TTHM | MCL EXCEEDANCE | 127.425 UG/L | 0.080 mg/L | 2022 | Archived |
| TTHM | MCL EXCEEDANCE | 107.225 UG/L | 0.080 mg/L | 2022 | Archived |
| TTHM | MCL EXCEEDANCE | 113.075 UG/L | 0.080 mg/L | 2022 | Archived |
| Total Haloacetic Acids (HAA5) | MONITORING AND REPORTING | — | 0.060 mg/L | 2022 | Archived |
| TTHM | MCL EXCEEDANCE | 105.875 UG/L | 0.080 mg/L | 2022 | Archived |
| TTHM | MCL EXCEEDANCE | 99.35 UG/L | 0.080 mg/L | 2021 | Resolved |
| TTHM | MCL EXCEEDANCE | 109.825 UG/L | 0.080 mg/L | 2021 | Resolved |
| TTHM | MCL EXCEEDANCE | 97.15 UG/L | 0.080 mg/L | 2021 | Resolved |
| TTHM | MCL EXCEEDANCE | 103.8 UG/L | 0.080 mg/L | 2021 | Resolved |
| TTHM | MCL EXCEEDANCE | 105.1 UG/L | 0.080 mg/L | 2020 | Resolved |
| TTHM | MCL EXCEEDANCE | 105.85 UG/L | 0.080 mg/L | 2020 | Resolved |
| TTHM | MCL EXCEEDANCE | 112.85 UG/L | 0.080 mg/L | 2020 | Resolved |
| TTHM | MCL EXCEEDANCE | 108.375 UG/L | 0.080 mg/L | 2020 | Resolved |
| TTHM | MCL EXCEEDANCE | 113.275 UG/L | 0.080 mg/L | 2019 | Resolved |
| TTHM | MCL EXCEEDANCE | 112.775 UG/L | 0.080 mg/L | 2019 | Resolved |
| TTHM | MCL EXCEEDANCE | 114.025 UG/L | 0.080 mg/L | 2019 | Resolved |
| Total Haloacetic Acids (HAA5) | MCL EXCEEDANCE | 65 UG/L | 0.060 mg/L | 2019 | Resolved |
| TTHM | MCL EXCEEDANCE | 124.5 UG/L | 0.080 mg/L | 2019 | Resolved |
| Total Haloacetic Acids (HAA5) | MCL EXCEEDANCE | 65.6 UG/L | 0.060 mg/L | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 116.8 UG/L | 0.080 mg/L | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 124.8167 UG/L | 0.080 mg/L | 2018 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2018 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 124.8167 UG/L | 0.080 mg/L | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 93.3833 UG/L | 0.080 mg/L | 2018 | Resolved |
| TTHM | MCL EXCEEDANCE | 105.7 UG/L | 0.080 mg/L | 2017 | Resolved |
| TTHM | MCL EXCEEDANCE | 88.38 UG/L | 0.080 mg/L | 2017 | Resolved |
| Revised Total Coliform Rule | MONITORING FAILURE | — | — | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2016 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2016 | Resolved |
| Coliform (TCR) | MONITORING AND REPORTING | — | 5% of samples | 2016 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2015 | Resolved |
| Coliform (TCR) | MONITORING AND REPORTING | — | 5% of samples | 2015 | Resolved |
| E. COLI | MONITORING AND REPORTING | — | 0 | 2015 | Resolved |
| Coliform (TCR) | MCL EXCEEDANCE | — | 5% of samples | 2015 | Resolved |